| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9888194 | Clinica Chimica Acta | 2005 | 8 Pages |
Abstract
The use of anti-CCP antibodies affords good clinical efficiency and modifies the pre-test probability of the occurrence of RA in patients with IgM rheumatoid factor higher than 20 IU/mL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Belén GarcÃa-Berrocal, Concepción González, Marta Pérez, José A. Navajo, Isabel Moreta, Carmen Dávila, José M. González-Buitrago,